Literature DB >> 7981417

Identification of novel glutathione conjugates of disulfiram and diethyldithiocarbamate in rat bile by liquid chromatography-tandem mass spectrometry. Evidence for metabolic activation of disulfiram in vivo.

L Jin1, M R Davis, P Hu, T A Baillie.   

Abstract

Recent studies have shown that the inhibitory effects of disulfiram and diethyldithiocarbamate (DDTC) (to which disulfiram is rapidly reduced in vivo) on the liver mitochondrial low-Km form of aldehyde dehydrogenase (ALDH) may be mediated by a reactive metabolite(s) of these compounds. In order to investigate the nature of such electrophilic intermediates in vivo, the present study was carried out with the goal of detecting and identifying their respective glutathione (GSH) conjugates in the bile of rats dosed ip with either disulfiram (75 mg kg-1) or sodium DDTC (114 mg kg-1). By means of highly selective screening strategies based on coupled liquid chromatography-tandem mass spectrometry techniques, one major and four minor GSH adducts were identified as common biliary metabolites of disulfiram and DDTC. The major conjugate, whose excretion into bile over 4 h accounted for ca. 1% of the dose of either precursor, was identified as S-(N,N-diethylcarbamoyl)glutathione (SDEG). In vitro experiments with synthetic SDEG demonstrated that this carbamate thioester derivative is chemically stable in aqueous media under physiological conditions and does not carbamoylate nucleophiles such as cysteine. Consistent with these findings, SDEG failed to inhibit yeast ALDH in vitro. The minor GSH conjugates in bile were identified as S-(N,N-diethylthiocarbamoyl)glutathione, S-(N-ethyl-carbamoyl)glutathione, S-(N-ethylthiocarbamoyl)glutathione, and S-[N-(carboxymethyl)-N- ethylcarbamoyl]glutathione, the structures of which indicate that metabolic oxidation takes place at the thiono sulfur group and at each of the carbon atoms of disulfiram and DDTC.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981417     DOI: 10.1021/tx00040a008

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  9 in total

1.  N-acetyl-S-(N,N-diethylcarbamoyl) cysteine in rat nucleus accumbens, medial prefrontal cortex, and in rat and human plasma after disulfiram administration.

Authors:  Robert D Winefield; Anthonius A M Heemskerk; Swetha Kaul; Todd D Williams; Michael J Caspers; Thomas E Prisinzano; Elinore F McCance-Katz; Craig E Lunte; Morris D Faiman
Journal:  J Pharm Biomed Anal       Date:  2015-01-25       Impact factor: 3.935

2.  Electrophilic adduction of ubiquitin activating enzyme E1 by N,N-diethyldithiocarbamate inhibits ubiquitin activation and is accompanied by striatal injury in the rat.

Authors:  Olga M Viquez; Samuel W Caito; W Hayes McDonald; David B Friedman; William M Valentine
Journal:  Chem Res Toxicol       Date:  2012-08-22       Impact factor: 3.739

3.  Determination of GABA, glutamate and carbamathione in brain microdialysis samples by capillary electrophoresis with fluorescence detection.

Authors:  Swetha Kaul; Morris D Faiman; Craig E Lunte
Journal:  Electrophoresis       Date:  2011-01       Impact factor: 3.535

4.  LC-MS/MS method for the determination of carbamathione in human plasma.

Authors:  Anthonius A M Heemskerk; Leon van Haandel; Joshua M Woods; Elinore F McCance-Katz; Todd D Williams; John F Stobaugh; Morris D Faiman
Journal:  J Pharm Biomed Anal       Date:  2010-11-02       Impact factor: 3.935

5.  Mechanism-based inactivation of human CYP2E1 by diethyldithocarbamate.

Authors:  Matthew Pratt-Hyatt; Hsia-lien Lin; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2010-09-08       Impact factor: 3.922

6.  LC-MS/MS determination of carbamathione in microdialysis samples from rat brain and plasma.

Authors:  Swetha Kaul; Todd D Williams; Craig E Lunte; Morris D Faiman
Journal:  J Pharm Biomed Anal       Date:  2009-07-30       Impact factor: 3.935

7.  S-(N, N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study.

Authors:  Morris D Faiman; Swetha Kaul; Shaheen A Latif; Todd D Williams; Craig E Lunte
Journal:  Neuropharmacology       Date:  2013-07-26       Impact factor: 5.250

8.  The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance.

Authors:  Juliana Almeida-Silva; Diego Silva Menezes; Juan Mateus Pereira Fernandes; Márcio Cerqueira Almeida; Deyvison Rhuan Vasco-Dos-Santos; Roberto Magalhães Saraiva; Alessandra Lifsitch Viçosa; Sandra Aurora Chavez Perez; Sônia Gumes Andrade; Ana Márcia Suarez-Fontes; Marcos André Vannier-Santos
Journal:  Front Cell Infect Microbiol       Date:  2022-07-29       Impact factor: 6.073

9.  Pharmacological evaluation of disulfiram analogs as antimicrobial agents and their application as inhibitors of fosB-mediated fosfomycin resistance.

Authors:  Alexandria D Lewis; Taylor M Riedel; Meredith B A Kesler; Melinda E Varney; Timothy E Long
Journal:  J Antibiot (Tokyo)       Date:  2022-01-20       Impact factor: 3.424

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.